KRAS inhibitor-31
KRAS inhibitor-31 (compound 33) is a KRAS inhibitor, with KD (SPR) values of 0.019 nM, 0.019 nM and 0.096 nM for KRas G12D, KRas G12C and KRas G12V, respectively[1].
Product Specifications
CAS Number
[2920695-77-6]
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-inhibitor-31.html
Purity
99.36
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC1=C(C2=CC(O)=CC3=C2C(C#C)=C(F)C=C3)N=C4OC[C@@](COCCC5)([H])N5C6=C4C1=NC(OC[C@@]78N(CCC8)C[C@@H](C7)F)=N6
Molecular Formula
C33H30F3N5O4
Molecular Weight
617.62
References & Citations
[1]Jacob Cole DEFOREST, et al. Pyrido[4,3-d]pyrimidine compounds. Patent WO2024009191.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
326137-01 50 µL
DFNA5 (ICERE1, Non-syndromic Hearing Impairment Protein 5, Inversely Correlated With Estrogen Receptor Expression 1, ICERE-1)
Ask
View Details 
326137-02 100 µL
DFNA5 (ICERE1, Non-syndromic Hearing Impairment Protein 5, Inversely Correlated With Estrogen Receptor Expression 1, ICERE-1)
Ask
View Details GTR15099141 1 Vial
Lentiviral human C17orf80 shRNA (UAS) - Lentiviral human C17orf80 shRNA (UAS, GFP) (100)
Ask
View Details